UNITEDHEALTH GROUP INC (UNH.DE) Stock Fundamental Analysis
Europe - FRA:UNH - US91324P1021 - Common Stock
274 EUR
-7.7 (-2.73%)
UNH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 27 industry peers in the Health Care Providers & Services industry. UNH has an average financial health and profitability rating. While showing a medium growth rate, UNH is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year UNH was profitable.
In the past year UNH had a positive cash flow from operations.
UNH had positive earnings in each of the past 5 years.
UNH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 5.58%, UNH belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
The Return On Equity of UNH (18.36%) is better than 92.59% of its industry peers.
The Return On Invested Capital of UNH (7.55%) is better than 81.48% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for UNH is above the industry average of 6.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.58% | ||
| ROE | 18.36% | ||
| ROIC | 7.55% |
ROA(3y)7.06%
ROA(5y)7.43%
ROE(3y)22.21%
ROE(5y)22.85%
ROIC(3y)10.14%
ROIC(5y)10.16%
1.3 Margins
Looking at the Profit Margin, with a value of 4.04%, UNH is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
In the last couple of years the Profit Margin of UNH has declined.
UNH has a Operating Margin (6.06%) which is comparable to the rest of the industry.
UNH's Operating Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.06% | ||
| PM (TTM) | 4.04% | ||
| GM | N/A |
OM growth 3Y-1.09%
OM growth 5Y-0.16%
PM growth 3Y-15.71%
PM growth 5Y-8.84%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UNH is still creating some value.
Compared to 1 year ago, UNH has less shares outstanding
The number of shares outstanding for UNH has been reduced compared to 5 years ago.
UNH has a worse debt/assets ratio than last year.
2.2 Solvency
UNH has an Altman-Z score of 2.89. This is not the best score and indicates that UNH is in the grey zone with still only limited risk for bankruptcy at the moment.
UNH's Altman-Z score of 2.89 is fine compared to the rest of the industry. UNH outperforms 77.78% of its industry peers.
The Debt to FCF ratio of UNH is 4.61, which is a neutral value as it means it would take UNH, 4.61 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of UNH (4.61) is better than 88.89% of its industry peers.
UNH has a Debt/Equity ratio of 0.76. This is a neutral value indicating UNH is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.76, UNH is in the better half of the industry, outperforming 62.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 4.61 | ||
| Altman-Z | 2.89 |
ROIC/WACC0.85
WACC8.91%
2.3 Liquidity
UNH has a Current Ratio of 0.95. This is a bad value and indicates that UNH is not financially healthy enough and could expect problems in meeting its short term obligations.
UNH has a Current ratio (0.95) which is comparable to the rest of the industry.
A Quick Ratio of 0.95 indicates that UNH may have some problems paying its short term obligations.
UNH has a Quick ratio (0.95) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.95 |
3. Growth
3.1 Past
UNH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.96%.
Measured over the past years, UNH shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.07% on average per year.
The Revenue has grown by 10.48% in the past year. This is quite good.
Measured over the past years, UNH shows a quite strong growth in Revenue. The Revenue has been growing by 10.57% on average per year.
EPS 1Y (TTM)-22.96%
EPS 3Y13.67%
EPS 5Y13.07%
EPS Q2Q%-59.16%
Revenue 1Y (TTM)10.48%
Revenue growth 3Y11.65%
Revenue growth 5Y10.57%
Sales Q2Q%12.24%
3.2 Future
UNH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.92% yearly.
The Revenue is expected to grow by 6.32% on average over the next years.
EPS Next Y-41.38%
EPS Next 2Y-20.24%
EPS Next 3Y-9.16%
EPS Next 5Y2.92%
Revenue Next Year11.68%
Revenue Next 2Y7.7%
Revenue Next 3Y6.86%
Revenue Next 5Y6.32%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
UNH is valuated correctly with a Price/Earnings ratio of 15.04.
Based on the Price/Earnings ratio, UNH is valued a bit cheaper than 74.07% of the companies in the same industry.
UNH is valuated rather cheaply when we compare the Price/Earnings ratio to 25.67, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 17.79, UNH is valued on the expensive side.
62.96% of the companies in the same industry are cheaper than UNH, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 31.86. UNH is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.04 | ||
| Fwd PE | 17.79 |
4.2 Price Multiples
UNH's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. UNH is more expensive than 70.37% of the companies in the same industry.
UNH's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.47 | ||
| EV/EBITDA | 11.33 |
4.3 Compensation for Growth
UNH has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as UNH's earnings are expected to decrease with -9.16% in the coming years.
PEG (NY)N/A
PEG (5Y)1.15
EPS Next 2Y-20.24%
EPS Next 3Y-9.16%
5. Dividend
5.1 Amount
UNH has a Yearly Dividend Yield of 2.56%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.55, UNH pays a better dividend. On top of this UNH pays more dividend than 81.48% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, UNH has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.56% |
5.2 History
On average, the dividend of UNH grows each year by 14.73%, which is quite nice.
Dividend Growth(5Y)14.73%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
UNH pays out 44.61% of its income as dividend. This is a bit on the high side, but may be sustainable.
UNH's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP44.61%
EPS Next 2Y-20.24%
EPS Next 3Y-9.16%
FRA:UNH (11/7/2025, 5:20:23 PM)
274
-7.7 (-2.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners86.49%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap248.15B
Revenue(TTM)435.16B
Net Income(TTM)17.59B
Analysts75.63
Price Target326.3 (19.09%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.56% |
Yearly Dividend7.09
Dividend Growth(5Y)14.73%
DP44.61%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.22%
Min EPS beat(2)-9.92%
Max EPS beat(2)3.48%
EPS beat(4)2
Avg EPS beat(4)-2.08%
Min EPS beat(4)-9.92%
Max EPS beat(4)3.48%
EPS beat(8)6
Avg EPS beat(8)0.38%
EPS beat(12)10
Avg EPS beat(12)0.9%
EPS beat(16)14
Avg EPS beat(16)1.67%
Revenue beat(2)0
Avg Revenue beat(2)-0.91%
Min Revenue beat(2)-0.91%
Max Revenue beat(2)-0.91%
Revenue beat(4)0
Avg Revenue beat(4)-1.63%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-0.91%
Revenue beat(8)2
Avg Revenue beat(8)-0.68%
Revenue beat(12)5
Avg Revenue beat(12)-0.31%
Revenue beat(16)7
Avg Revenue beat(16)-0.21%
PT rev (1m)9.89%
PT rev (3m)-1.99%
EPS NQ rev (1m)1.28%
EPS NQ rev (3m)-51.84%
EPS NY rev (1m)-0.11%
EPS NY rev (3m)-26.66%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-0.72%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.04 | ||
| Fwd PE | 17.79 | ||
| P/S | 0.66 | ||
| P/FCF | 16.47 | ||
| P/OCF | 13.65 | ||
| P/B | 2.99 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.33 |
EPS(TTM)18.22
EY6.65%
EPS(NY)15.4
Fwd EY5.62%
FCF(TTM)16.64
FCFY6.07%
OCF(TTM)20.07
OCFY7.33%
SpS416.62
BVpS91.71
TBVpS-35.75
PEG (NY)N/A
PEG (5Y)1.15
Graham Number193.89
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.58% | ||
| ROE | 18.36% | ||
| ROCE | 9.71% | ||
| ROIC | 7.55% | ||
| ROICexc | 8.39% | ||
| ROICexgc | 23.23% | ||
| OM | 6.06% | ||
| PM (TTM) | 4.04% | ||
| GM | N/A | ||
| FCFM | 3.99% |
ROA(3y)7.06%
ROA(5y)7.43%
ROE(3y)22.21%
ROE(5y)22.85%
ROIC(3y)10.14%
ROIC(5y)10.16%
ROICexc(3y)11.32%
ROICexc(5y)11.36%
ROICexgc(3y)32.46%
ROICexgc(5y)32.01%
ROCE(3y)13.1%
ROCE(5y)13.1%
ROICexgc growth 3Y-2.11%
ROICexgc growth 5Y-0.12%
ROICexc growth 3Y-2.38%
ROICexc growth 5Y-0.43%
OM growth 3Y-1.09%
OM growth 5Y-0.16%
PM growth 3Y-15.71%
PM growth 5Y-8.84%
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover1.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 4.61 | ||
| Debt/EBITDA | 2.36 | ||
| Cap/Depr | 83.69% | ||
| Cap/Sales | 0.82% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 68.42% | ||
| Profit Quality | 98.8% | ||
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.95 | ||
| Altman-Z | 2.89 |
F-Score9
WACC8.91%
ROIC/WACC0.85
Cap/Depr(3y)84.34%
Cap/Depr(5y)80.61%
Cap/Sales(3y)0.88%
Cap/Sales(5y)0.86%
Profit Quality(3y)124.43%
Profit Quality(5y)123.8%
High Growth Momentum
Growth
EPS 1Y (TTM)-22.96%
EPS 3Y13.67%
EPS 5Y13.07%
EPS Q2Q%-59.16%
EPS Next Y-41.38%
EPS Next 2Y-20.24%
EPS Next 3Y-9.16%
EPS Next 5Y2.92%
Revenue 1Y (TTM)10.48%
Revenue growth 3Y11.65%
Revenue growth 5Y10.57%
Sales Q2Q%12.24%
Revenue Next Year11.68%
Revenue Next 2Y7.7%
Revenue Next 3Y6.86%
Revenue Next 5Y6.32%
EBIT growth 1Y-18.15%
EBIT growth 3Y10.44%
EBIT growth 5Y10.4%
EBIT Next Year-25.01%
EBIT Next 3Y-3.56%
EBIT Next 5Y4.32%
FCF growth 1Y-34.26%
FCF growth 3Y0.99%
FCF growth 5Y4.56%
OCF growth 1Y-29.48%
OCF growth 3Y2.39%
OCF growth 5Y5.37%
UNITEDHEALTH GROUP INC / UNH.DE FAQ
Can you provide the ChartMill fundamental rating for UNITEDHEALTH GROUP INC?
ChartMill assigns a fundamental rating of 5 / 10 to UNH.DE.
What is the valuation status for UNH stock?
ChartMill assigns a valuation rating of 3 / 10 to UNITEDHEALTH GROUP INC (UNH.DE). This can be considered as Overvalued.
Can you provide the profitability details for UNITEDHEALTH GROUP INC?
UNITEDHEALTH GROUP INC (UNH.DE) has a profitability rating of 6 / 10.
What is the valuation of UNITEDHEALTH GROUP INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for UNITEDHEALTH GROUP INC (UNH.DE) is 15.04 and the Price/Book (PB) ratio is 2.99.
What is the financial health of UNITEDHEALTH GROUP INC (UNH.DE) stock?
The financial health rating of UNITEDHEALTH GROUP INC (UNH.DE) is 5 / 10.